IPHA (IPHA) Stock Price & Analysis
IPHA (IPHA) fell 1.92% to USD 2.04 as of September 8, 2026 at 16:49 UTC, according to Nexqual real-time market data.
IPHA last closed at USD 2.04; the session ranged USD 2.01–2.05 on volume of 16,395 shares. Market capitalization is —, with a 52-week range of USD 1.17–2.71 (NMS). Source: Nexqual, September 8, 2026 at 16:49 UTC.
Key Statistics (as of September 8, 2026 at 16:49 UTC)
| Price | USD 2.04 |
|---|---|
| Change | ▼ 1.92% (down) |
| Previous Close | USD 2.04 |
| Open | USD 2.04 |
| Day Range | USD 2.01 – 2.05 |
| 52-Week Range | USD 1.17 – 2.71 |
| Volume | 16,395 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (IPHA)
Nexqual's technical model rates IPHA "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 16:49 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 48.02 (neutral) |
| vs SMA50 | Above (USD 1.96) |
| MACD | 0.04 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | USD 1.79 | ▲ 53.88% |
| FULC | Fulcrum Therapeutics, Inc. | USD 3.83 | ▼ 0.39% |
| BYSI | BeyondSpring, Inc. | USD 0.61 | ▼ 2.73% |
| ZIVO | Zivo Bioscience, Inc. | USD 3.01 | ▼ 16.39% |
| IFRX | InflaRx N.V. | USD 2.18 | ▼ 2.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:49 UTC. This page is informational and not investment advice.